CLINICAL_TRIALS
trial_result
· 2012-03-27
Clinical Trial Update: An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer [Phase 2]
Summary
A Phase 2 trial evaluating MORAb-009 (amatuximab) for pancreatic cancer has completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Morphotek | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-03-27